Skip to main content
Year archive

MAXCYTE, INC. — 2023 filings

All 131 regulatory filings released by MAXCYTE, INC. (MXCT) in 2023, sourced directly from the official regulator.

131 Filings
2023 Period
2023 filings (131)
Filing Released Lang
Exercise of options and PDMR dealing
Director's Dealing
2023-12-29 English
FORM 4 SUBMISSION
Director's Dealing
2023-12-28 English
CEO Transition and Revenue Guidance Update
Regulatory Filings
2023-12-12 English
8-K
Regulatory Filings
2023-12-11 English
Exercise of options and PDMR dealing
Director's Dealing
2023-12-07 English
FORM 4 SUBMISSION
Director's Dealing
2023-12-06 English
Exercise of options and PDMR dealing
Director's Dealing
2023-12-04 English
Total Voting Rights
Regulatory Filings
2023-12-01 English
FORM 4 SUBMISSION
Director's Dealing
2023-12-01 English
Exercise of options and PDMR dealing
Director's Dealing
2023-11-30 English
FORM 4 SUBMISSION
Director's Dealing
2023-11-29 English
Regulatory Filings 2023
Regulatory Filings
2023-11-29 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-11-17 English
Exercise of options and PDMR dealing
Director's Dealing
2023-11-17 English
FORM 4 SUBMISSION
Director's Dealing
2023-11-16 English
MaxCyte Joins the Alliance for mRNA Medicines
Regulatory Filings
2023-11-16 English
Regulatory Filings 2023
Regulatory Filings
2023-11-14 English
Filing of Form 10-Q
Report Publication Announcement
2023-11-09 English
Third Quarter Results
Earnings Release Q3 2023
2023-11-09 English
10-Q
Interim / Quarterly Report Q3 2023
2023-11-08 English
8-K
Regulatory Filings
2023-11-08 English
Participation in Upcoming Investor Conferences
Regulatory Filings
2023-11-07 English
Total Voting Rights
Regulatory Filings
2023-11-01 English
Preliminary Q3 Revenue & FY Revenue Guidance
Earnings Release Q3 2023
2023-10-05 English
8-K
Regulatory Filings
2023-10-04 English
Total Voting Rights
Regulatory Filings
2023-10-02 English
TR-1: Notification of major holdings
Major Shareholding Notification
2023-09-13 English
TR-1: Notification of major holdings
Major Shareholding Notification
2023-09-12 English
Appointment of Executive VP of Bioprocessing
Board/Management Information
2023-09-06 English
TR-1: Notification of major holdings
Major Shareholding Notification
2023-09-05 English
Baird Global Healthcare Conference Participation
Regulatory Filings
2023-09-05 English
TR-1: Notification of major holdings
Major Shareholding Notification
2023-09-04 English
Total Voting Rights
Regulatory Filings
2023-09-04 English
Exercise of options and PDMR dealing
Director's Dealing
2023-09-01 English
FORM 4 SUBMISSION
Director's Dealing
2023-08-30 English
TR-1
Major Shareholding Notification
2023-08-18 English
TR-1: Notification of major holdings
Major Shareholding Notification
2023-08-17 English
TR-1: Notification of Major Holdings
Major Shareholding Notification
2023-08-17 English
Filing of Form 10-Q
Report Publication Announcement
2023-08-10 English
Second Quarter and Half-Year Results
Earnings Release H1 2023
2023-08-10 English
10-Q
Interim / Quarterly Report Q2 2023
2023-08-09 English
8-K
Regulatory Filings
2023-08-09 English
TR-1: Notification of major holdings
Major Shareholding Notification
2023-08-08 English
Total Voting Rights and Block Listing Return
Regulatory Filings
2023-08-07 English
Strategic Platform License with Prime Medicine
Regulatory Filings
2023-08-01 English
Exercise of options and PDMR dealing
Director's Dealing
2023-07-31 English
FORM 4 SUBMISSION
Director's Dealing
2023-07-28 English
TR-1: Notification of major holdings
Major Shareholding Notification
2023-07-26 English
TR-1: Notification of major holdings
Major Shareholding Notification
2023-07-24 English
TR-1: Notification of major holdings
Major Shareholding Notification
2023-07-24 English
Notice of Second Quarter 2023 Financial Results
Report Publication Announcement
2023-07-13 English
FORM 4 SUBMISSION
Director's Dealing
2023-07-12 English
TR-1: Notification of major holdings
Major Shareholding Notification
2023-07-11 English
Regulatory Filings 2023
Regulatory Filings
2023-07-10 English
Signing of Strategic Platform License
Regulatory Filings
2023-07-10 English
TR-1: Notification of major holdings
Major Shareholding Notification
2023-07-10 English
Total Voting Rights
Share Issue/Capital Change
2023-07-07 English
TR-1: Notification of major holdings
Major Shareholding Notification
2023-07-06 English
Signing of Strategic Platform License
Regulatory Filings
2023-07-06 English
TR-1: Notification of major holdings
Major Shareholding Notification
2023-06-29 English
TR-1: Notification of major holdings
Major Shareholding Notification
2023-06-29 English
Exercise of options and PDMR dealing
Director's Dealing
2023-06-29 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-28 English
Regulatory Filings 2023
Regulatory Filings
2023-06-26 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-23 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-23 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-23 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-23 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-23 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-23 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-23 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-23 English
Grant of Options
Director's Dealing
2023-06-23 English
FORM 8-K
Regulatory Filings
2023-06-23 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2023-06-23 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2023-06-23 English
Publication of Annual Report
Report Publication Announcement
2023-06-21 English
Exercise of options and PDMR dealing
Director's Dealing
2023-06-16 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-15 English
Upcoming Investor Conferences
Regulatory Filings
2023-06-02 English
Total Voting Rights
Regulatory Filings
2023-06-01 English
Filing of Form 10-Q
Report Publication Announcement
2023-05-11 English
First Quarter Financial Results
Earnings Release Q1 2023
2023-05-11 English
10-Q
Interim / Quarterly Report Q1 2023
2023-05-10 English
8-K
Regulatory Filings
2023-05-10 English
Exercise of options and PDMR dealing
Director's Dealing
2023-05-09 English
FORM 4 SUBMISSION
Director's Dealing
2023-05-05 English
Signing of Strategic Platform License
Regulatory Filings
2023-05-04 English
Director/PDMR Shareholding
Director's Dealing
2023-05-03 English
ARS
Annual Report
2023-04-28 English
DEF 14A
Proxy Solicitation & Information Statement
2023-04-28 English
Notice of First Quarter 2023 Financial Results
Report Publication Announcement
2023-04-13 English
FORM 4 SUBMISSION
Director's Dealing
2023-04-12 English
FORM 4 SUBMISSION
Director's Dealing
2023-04-12 English
FORM 4 SUBMISSION
Director's Dealing
2023-04-07 English
FORM 4 SUBMISSION
Director's Dealing
2023-04-07 English
FORM 4 SUBMISSION
Director's Dealing
2023-04-04 English
FORM 4 SUBMISSION
Director's Dealing
2023-04-04 English
Director/PDMR Shareholding
Director's Dealing
2023-03-30 English
FORM 4 SUBMISSION
Director's Dealing
2023-03-30 English
FORM 4 SUBMISSION
Director's Dealing
2023-03-28 English
FORM 3 SUBMISSION
Director's Dealing
2023-03-28 English
FORM 8-K
Regulatory Filings
2023-03-28 English
Appointment of Chief Financial Officer
Board/Management Information
2023-03-28 English
Grant of Options and PDMR Dealing
Director's Dealing
2023-03-22 English
FORM 4 SUBMISSION
Director's Dealing
2023-03-21 English
FORM 4 SUBMISSION
Director's Dealing
2023-03-21 English
FORM 4 SUBMISSION
Director's Dealing
2023-03-21 English
FORM 4 SUBMISSION
Director's Dealing
2023-03-21 English
FORM 4 SUBMISSION
Director's Dealing
2023-03-21 English
FORM 4 SUBMISSION
Director's Dealing
2023-03-21 English
FORM 4 SUBMISSION
Director's Dealing
2023-03-21 English
Filing of Form 10-K
Report Publication Announcement
2023-03-16 English
2022 Full Year Results
Earnings Release Q4 2022
2023-03-16 English
10-K
Annual Report FY 2022
2023-03-15 English
8-K
Regulatory Filings
2023-03-15 English
Establishment of New Scientific Advisory Board
Regulatory Filings
2023-03-08 English
Preliminary Unaudited Q4 &FY 2022 Revenue Results
Earnings Release Q4 2022
2023-03-07 English
8-K
Regulatory Filings
2023-03-06 English
NONE
Major Shareholding Notification
2023-02-14 English
SC 13G/A
Major Shareholding Notification
2023-02-13 English
Director/PDMR Shareholding
Director's Dealing
2023-02-06 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-03 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-03 English
Notice of Results
Regulatory Filings
2023-02-02 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-01-31 English
Exercise of options and PDMR dealing
Director's Dealing
2023-01-30 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-01-10 English
FORM 4 SUBMISSION
Director's Dealing
2023-01-05 English
FORM 4 SUBMISSION
Director's Dealing
2023-01-05 English
Signing of Strategic Platform License
Regulatory Filings
2023-01-04 English